Company: IMCR
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001140361-25-012123
Chunk: 1

Company: Immunocore Holdings plc
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 1
---
 the ADS proxy card provided to you. Please carefully review the instructions on each of your voting options described in this proxy statement, the notice, and, if applicable, the voting instructions. Thank you for your ongoing support of and continued interest in Immunocore Holdings plc. We look forward to receiving your vote in respect of the business to be conducted at the AGM. Yours sincerely, /s/ Professor Sir John Bell Professor Sir John Bell Chairman

TABLE OF CONTENTS

Immunocore Holdings plc (incorporated and registered in England and Wales under the Companies Act 2006 with registered number 13119746) 92 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS To Be Held On May 15, 2025 NOTICE is hereby given that the 2025 Annual General Meeting (the “AGM”) of Immunocore Holdings plc, a public limited company incorporated under the laws of England and Wales (referred to herein as the “Company,” “we,” “us” and “our”), will be held on Thursday, May 15, 2025, at 2:30 p.m. London time (9:30 a.m. Eastern Daylight Time), at the offices of Cooley (UK) LLP, 22 Bishopsgate, London EC2N 4BQ, United Kingdom and electronically via meetnow.global/IHCAGM2025 , for transaction of the following business: Ordinary Resolutions

| 1. | To re-appoint as a director Roy S. Herbst, M.D., Ph.D., who retires in accordance with the articles of association. |

| 2. | To re-appoint as a director Ranjeev Krishana, who retires in accordance with the articles of association. |

| 3. | To re-appoint as a director Professor Sir Peter Ratcliffe, who retires in accordance with the articles of association. |

| 4. | To approve, on advisory basis, the compensation of our named executive officers, as disclosed in the attached proxy statement. |

| 6. | To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of our next annual general meeting of shareholders. |

| 10. | To approve the directors’ remuneration policy, which is set forth